GLP1R and X-linked cone dysfunction syndrome with myopia: These findings are in keeping with pilot clinical studies showing a beneficial effect of GLP-1 receptor agonists on binge-eating [20, 21] and confirms the need for larger clinical trials of this class of drugs in BED.